Dendritic cell targeted HIV‐1 gag protein vaccine provides help to a recombinant Newcastle disease virus vectored vaccine including mobilization of protective CD8(+) T cells

INTRODUCTION: Recombinant Newcastle Disease virus (rNDV) vectored vaccines are safe mucosal applicable vaccines with intrinsic immune‐modulatory properties for the induction of efficient immunity. Like all viral vectored vaccines repeated inoculation via mucosal routes invariably results to immunity...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngu, Loveline N., Nji, Nadesh N., Ambada, Georgia, Ngoh, Apeh A., Njambe Priso, Ghislain D., Tchadji, Jules C., Lissom, Abel, Magagoum, Suzanne H., Sake, Carol N., Tchouangueu, Thibau F., Chukwuma, George O., Okoli, Arinze S., Sagnia, Bertrand, Chukwuanukwu, Rebecca, Tebit, Denis M., Esimone, Charles O., Waffo, Alain B., Park, Chae G., Überla, Klaus, Nchinda, Godwin W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818444/
https://www.ncbi.nlm.nih.gov/pubmed/29205929
http://dx.doi.org/10.1002/iid3.209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818444/
https://www.ncbi.nlm.nih.gov/pubmed/29205929
http://dx.doi.org/10.1002/iid3.209

Ejemplares similares